Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zepp Health (ZEPP) Income towards Parent Company (2016 - 2025)

Zepp Health has reported Income towards Parent Company over the past 10 years, most recently at $135000.0 for Q4 2025.

  • For Q4 2025, Income towards Parent Company fell 98.03% year-over-year to $135000.0; the TTM value through Dec 2025 reached -$19.5 million, up 19.93%, while the annual FY2025 figure was -$35.8 million, N/A changed from the prior year.
  • Income towards Parent Company for Q4 2025 was $135000.0 at Zepp Health, down from $1.0 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $15.2 million in Q2 2021 and troughed at -$24.9 million in Q1 2022.
  • A 5-year average of -$5.1 million and a median of -$7.2 million in 2021 define the central range for Income towards Parent Company.
  • On a YoY basis, Income towards Parent Company climbed as much as 394.14% in 2021 and fell as far as 369.05% in 2021.
  • Year by year, Income towards Parent Company stood at $4.4 million in 2021, then tumbled by 275.6% to -$7.7 million in 2022, then surged by 173.85% to $5.7 million in 2023, then grew by 21.01% to $6.9 million in 2024, then tumbled by 98.03% to $135000.0 in 2025.
  • Business Quant data shows Income towards Parent Company for ZEPP at $135000.0 in Q4 2025, $1.0 million in Q3 2025, and -$4.3 million in Q2 2025.